Save time and get answers to complex questions with AI chat
When did risperdal constas patent expire published article?Bortezomib market france?Drugpatentwatch trametinib?Tracleer online pharmacy?Is januvia still on the market?
See the DrugPatentWatch profile for lumigan
Lumigan eye drops (bimatoprost) are made by Allergan (its brand is part of AbbVie’s portfolio) and are marketed under the Lumigan name for the treatment of elevated intraocular pressure in conditions such as glaucoma and ocular hypertension. [1]
Yes. Depending on the country, the product may be marketed by a local affiliate or distributor even if the underlying product is associated with the original brand manufacturer. Labeling on the specific package or the local prescribing information can confirm the exact manufacturer or marketing authorization holder for that region. [1]
For the most accurate answer for your exact product, look for the “manufactured by” or “marketing authorization holder” line on the carton or patient leaflet. That line can differ by jurisdiction even when the active ingredient (bimatoprost) and brand (Lumigan) are the same. [1] Sources: [1] DrugPatentWatch.com – Lumigan (bimatoprost) information page: https://www.drugpatentwatch.com/
Other Questions About Lumigan :